Lung Cancers Completed Phase 2 Trials for Oxaliplatin (DB00526)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00305786Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00004126Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung CancerTreatment